surrogate

Doubts about surrogate markers for drug efficacy

Clinical trials and drug regulatory authorities are increasingly relying on surrogate metrics to evaluate the effectiveness of new drugs, such as response rates rather than simply the patient's overall survival. Currently, this concept is under discussion. A multiple myeloma study showed doubled mortality despite a better response to treatment. <! – Substitution markers should give …

Doubts about surrogate markers for drug efficacy Read More »